Singapore markets closed

Kinarus Therapeutics Holding AG (FMZ.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.01750.0000 (0.00%)
At close: 06:47PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
716
716
1,507
0
Selling general and administrative
1,286
1,286
1,631
410
Total operating expenses
3,535
3,535
1,840
410
Operating income or loss
-3,535
-3,535
-1,840
-410
Interest expense
13
13
6
9
Income before tax
-50,762
-50,762
-39,899
-143
Income tax expense
-1,382
-1,382
-5,156
0
Income from continuing operations
-49,380
-49,380
-34,743
-143
Net income
-49,380
-49,380
-34,732
-143
Net income available to common shareholders
-49,380
-49,380
-34,732
-143
Basic EPS
-217.68
-176.38
-221.63
-3.90
Diluted EPS
-217.68
-176.38
-221.63
-3.90
Basic average shares
255.974
279.975
156.719
36.555
Diluted average shares
255.974
279.975
156.719
36.555